These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 11347507
1. [Clinical features and response to systemic treatment of primary and secondary episcleritis and scleritis resistant to local treatment]. Cuchacovich T M, Pacheco P, Merino G, Gallardo P, Gatica H, Valenzuela H, Verdaguer J, Verdaguer J. Rev Med Chil; 2000 Nov; 128(11):1205-14. PubMed ID: 11347507 [Abstract] [Full Text] [Related]
2. Severity of scleritis and episcleritis. Sainz de la Maza M, Jabbur NS, Foster CS. Ophthalmology; 1994 Feb; 101(2):389-96. PubMed ID: 8115160 [Abstract] [Full Text] [Related]
3. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Ophthalmology; 2012 Jan; 119(1):43-50. PubMed ID: 21963265 [Abstract] [Full Text] [Related]
5. [Study on the clinical manifestation of 90 cases with scleritis and episcleritis]. Zhou Y, Wang Z, Zhang Y, Sun X. Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):261-6. PubMed ID: 24931151 [Abstract] [Full Text] [Related]
7. Clinical features of patients with episcleritis and scleritis in an Italian tertiary care referral center. Berchicci L, Miserocchi E, Di Nicola M, La Spina C, Bandello F, Modorati G. Eur J Ophthalmol; 2014 Apr; 24(3):293-8. PubMed ID: 24242216 [Abstract] [Full Text] [Related]
9. [Indication and effect of immunosuppression in patients with scleritis]. Heiligenhaus A, Dück N, Michel D, Hudde T, Koch J, Steuhl KP. Klin Monbl Augenheilkd; 2003 Jul; 220(7):471-80. PubMed ID: 12886507 [Abstract] [Full Text] [Related]
10. [Episcleritis and scleritis. An overview of modern diagnostic and therapeutic concepts]. Denk PO, Thiel HJ, Zierhut M. Klin Monbl Augenheilkd; 1997 Sep; 211(3):140-50. PubMed ID: 9445894 [Abstract] [Full Text] [Related]
11. Clinical characteristics of scleritis patients with emphasized comparison of associated systemic diseases (anti-neutrophil cytoplasmic antibody-associated vasculitis and rheumatoid arthritis). Yoshida A, Watanabe M, Okubo A, Kawashima H. Jpn J Ophthalmol; 2019 Sep; 63(5):417-424. PubMed ID: 31183624 [Abstract] [Full Text] [Related]
17. [New clinical and epidemiologic aspects of episcleritis and scleritis]. Denk PO, Rohrbach JM, Thiel HJ, Zierhut M. Ophthalmologe; 1997 Mar; 94(3):202-5. PubMed ID: 9181836 [Abstract] [Full Text] [Related]
18. Smoking delays the response to treatment in episcleritis and scleritis. Boonman ZF, de Keizer RJ, Watson PG. Eye (Lond); 2005 Sep; 19(9):949-55. PubMed ID: 15543188 [Abstract] [Full Text] [Related]
19. Clinical features of episcleritis and scleritis in some Japanese patients. Nakajima N, Hayasaka S. Ophthalmologica; 1995 Sep; 209(5):256-9. PubMed ID: 8570148 [Abstract] [Full Text] [Related]